Matthias Briel
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
Herbrand A, Hemkens L, Novak U, Moffa G, Jörger M, Hoogkamer A, Diem S, Goldkuhle M, Ewald H, Briel M, Schmitt A, Kasenda B. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA Netw Open 2021; 4:e210380.
01.03.2021Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
01.03.2021JAMA Netw Open 2021; 4:e210380
Herbrand Amanda Katherina, Hemkens Lars G, Novak Urban, Moffa Giusi, Jörger Markus, Hoogkamer Anouk, Diem Stefan, Goldkuhle Marius, Ewald Hannah, Briel Matthias, Schmitt Andreas M, Kasenda Benjamin
Uncertainties about the need for ethics approval in Switzerland: a mixed-methods study.
Gloy V, McLennan S, Rinderknecht M, Ley B, Meier B, Driessen S, Gervasoni P, Hirschel B, Benkert P, Gilles I, von Elm E, Briel M. Uncertainties about the need for ethics approval in Switzerland: a mixed-methods study. Swiss Med Wkly 2020; 150:w20318.
12.08.2020Uncertainties about the need for ethics approval in Switzerland: a mixed-methods study.
12.08.2020Swiss Med Wkly 2020; 150:w20318
Gloy Viktoria, McLennan Stuart, Rinderknecht Matthias, Ley Bettina, Meier Brigitte, Driessen Susanne, Gervasoni Pietro, Hirschel Bernard, Benkert Pascal, Gilles Ingrid, von Elm Erik, Briel Matthias
Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
Herbrand A, Hemkens L, Sricharoenchai S, Novak U, Mc Cord K, Jörger M, Hoogkamer A, Ewald H, Diem S, Briel M, Schmitt A, Kasenda B. Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO Open 2019; 4:e000596.
01.12.2019Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
01.12.2019ESMO Open 2019; 4:e000596
Herbrand Amanda Katherina, Hemkens Lars G, Sricharoenchai Sirintip, Novak Urban, Mc Cord Kimberly Alba, Jörger Markus, Hoogkamer Anouk, Ewald Hannah, Diem Stefan, Briel Matthias, Schmitt Andreas Michael, Kasenda Benjamin
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
Leuppi J, Tamm M, von Garnier C, Viatte S, Stoeckli R, Schindler C, Scherr A, Müller B, Miedinger D, Maier S, Leibbrandt Y, Henzen C, Duerring U, Drescher T, Briel M, Bodmer M, Bingisser R, Schuetz P, Rutishauser J. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309:2223-31.
05.06.2013Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
05.06.2013JAMA 2013; 309:2223-31
Leuppi Jörg D, Tamm Michael, von Garnier Christophe, Viatte Sebastien, Stoeckli Rolf, Schindler Christian, Scherr Andreas, Müller Beat, Miedinger David, Maier Sabrina, Leibbrandt Yolanda, Henzen Christoph, Duerring Ursula, Drescher Tilman, Briel Matthias, Bodmer Michael, Bingisser Roland, Schuetz Philipp, Rutishauser Jonas